rs398123566

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP3BP6_Very_StrongBS2

The NM_001110792.2(MECP2):​c.15_23delCGCCGCCGC​(p.Ala6_Ala8del) variant causes a disruptive inframe deletion change. The variant allele was found at a frequency of 0.0000898 in 1,024,866 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 27 hemizygotes in GnomAD. Variant has been reported in ClinVar as Benign (★★★). Synonymous variant affecting the same amino acid position (i.e. A5A) has been classified as Likely benign. The gene MECP2 is included in the ClinGen Criteria Specification Registry.

Frequency

Genomes: 𝑓 0.000028 ( 0 hom., 1 hem., cov: 21)
Exomes 𝑓: 0.000097 ( 0 hom. 26 hem. )

Consequence

MECP2
NM_001110792.2 disruptive_inframe_deletion

Scores

Not classified

Clinical Significance

Benign reviewed by expert panel U:2B:6

Conservation

PhyloP100: 4.00

Publications

3 publications found
Variant links:
Genes affected
MECP2 (HGNC:6990): (methyl-CpG binding protein 2) DNA methylation is the major modification of eukaryotic genomes and plays an essential role in mammalian development. Human proteins MECP2, MBD1, MBD2, MBD3, and MBD4 comprise a family of nuclear proteins related by the presence in each of a methyl-CpG binding domain (MBD). Each of these proteins, with the exception of MBD3, is capable of binding specifically to methylated DNA. MECP2, MBD1 and MBD2 can also repress transcription from methylated gene promoters. In contrast to other MBD family members, MECP2 is X-linked and subject to X inactivation. MECP2 is dispensible in stem cells, but is essential for embryonic development. MECP2 gene mutations are the cause of most cases of Rett syndrome, a progressive neurologic developmental disorder and one of the most common causes of cognitive disability in females. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Oct 2015]
MECP2 Gene-Disease associations (from GenCC):
  • chromosome Xq28 duplication syndrome
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • Rett syndrome
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: ClinGen, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P, Orphanet
  • severe neonatal-onset encephalopathy with microcephaly
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • syndromic X-linked intellectual disability Lubs type
    Inheritance: XL Classification: DEFINITIVE Submitted by: G2P
  • atypical Rett syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • non-syndromic X-linked intellectual disability
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • X-linked intellectual disability-psychosis-macroorchidism syndrome
    Inheritance: XL Classification: SUPPORTIVE Submitted by: Orphanet
  • systemic lupus erythematosus
    Inheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_001110792.2, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP3
Nonframeshift variant in repetitive region in NM_001110792.2
BP6
Variant X-154097642-CGCGGCGGCG-C is Benign according to our data. Variant chrX-154097642-CGCGGCGGCG-C is described in ClinVar as Benign. ClinVar VariationId is 193163.Status of the report is reviewed_by_expert_panel, 3 stars.
BS2
High AC in GnomAdExome4 at 89 XL,Unknown,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001110792.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
NM_001110792.2
MANE Select
c.15_23delCGCCGCCGCp.Ala6_Ala8del
disruptive_inframe_deletion
Exon 1 of 3NP_001104262.1A0A140VKC4
MECP2
NM_004992.4
MANE Plus Clinical
c.-146_-138delCGCCGCCGC
5_prime_UTR
Exon 1 of 4NP_004983.1D3YJ43
MECP2
NM_001316337.2
c.-593_-585delCGCCGCCGC
5_prime_UTR
Exon 1 of 5NP_001303266.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
MECP2
ENST00000453960.7
TSL:1 MANE Select
c.15_23delCGCCGCCGCp.Ala6_Ala8del
disruptive_inframe_deletion
Exon 1 of 3ENSP00000395535.2P51608-2
MECP2
ENST00000303391.11
TSL:1 MANE Plus Clinical
c.-146_-138delCGCCGCCGC
5_prime_UTR
Exon 1 of 4ENSP00000301948.6P51608-1
MECP2
ENST00000631210.1
TSL:1
n.305+7130_305+7138delCGCCGCCGC
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.0000282
AC:
3
AN:
106553
Hom.:
0
Cov.:
21
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000393
Gnomad OTH
AF:
0.000695
GnomAD2 exomes
AF:
0.0000500
AC:
3
AN:
59976
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000113
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000969
AC:
89
AN:
918313
Hom.:
0
AF XY:
0.0000912
AC XY:
26
AN XY:
284941
show subpopulations
African (AFR)
AF:
0.0000504
AC:
1
AN:
19838
American (AMR)
AF:
0.0000584
AC:
1
AN:
17111
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
13271
East Asian (EAS)
AF:
0.00
AC:
0
AN:
22385
South Asian (SAS)
AF:
0.0000944
AC:
3
AN:
31778
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
21634
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3234
European-Non Finnish (NFE)
AF:
0.000106
AC:
80
AN:
752170
Other (OTH)
AF:
0.000108
AC:
4
AN:
36892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.445
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000282
AC:
3
AN:
106553
Hom.:
0
Cov.:
21
AF XY:
0.0000331
AC XY:
1
AN XY:
30189
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
29680
American (AMR)
AF:
0.00
AC:
0
AN:
10343
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2596
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3256
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2499
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
5017
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
230
European-Non Finnish (NFE)
AF:
0.0000393
AC:
2
AN:
50882
Other (OTH)
AF:
0.000695
AC:
1
AN:
1438
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.425
Heterozygous variant carriers
0
1
1
2
2
3
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
4
Bravo
AF:
0.0000604

ClinVar

ClinVar submissions
Significance:Benign
Revision:reviewed by expert panel
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
not provided (2)
-
-
2
not specified (2)
-
-
2
Rett syndrome (2)
-
-
1
MECP2-related disorder (1)
-
-
1
Severe neonatal-onset encephalopathy with microcephaly (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
PhyloP100
4.0

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs398123566;
hg19: chrX-153363099;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.